Metformin does not improve insulin sensitivity over hypocaloric diets in women with polycystic ovary syndrome: a systematic review of 12 studies

References

• Franik S, Eltrop SM, Kremer JA, et al. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;5(5):CD010287.
   PubMedGoogle Scholar
• Meier RK. Polycystic Ovary Syndrome. Nurs Clin North Am. 2018;53(3):407–420.
   PubMed Web of Science ®Google Scholar
• Cree-Green M, Rahat H, Newcomer BR, et al. Insulin resistance, hyperinsulinemia, and mitochondria dysfunction in nonobese girls with polycystic ovarian syndrome. J Endocrine Soc. 2017;1(7):931–944.
   PubMed Web of Science ®Google Scholar
• Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15.
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.
   PubMed Web of Science ®Google Scholar
• Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095–1105.
   PubMed Web of Science ®Google Scholar
• Barber TM, Golding SJ, Alvey C, et al. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(3):999–1004.
   PubMed Web of Science ®Google Scholar
• Huang ZH, Manickam B, Ryvkin V, et al. PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity. J Clin Endocrinol Metab. 2013;98(1):E17–24.
   PubMed Web of Science ®Google Scholar
• Porchia LM, Hernandez-Garcia SC, Gonzalez-Mejia ME, et al. Diets with lower carbohydrate concentrations improve insulin sensitivity in women with polycystic ovary syndrome: a meta-analysis. Euro J Obstetr Gynecol Reproduct Biol. 2020;248:110–117.
   PubMed Web of Science ®Google Scholar
• Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2016;164(11):740–751.
   PubMed Web of Science ®Google Scholar
• Amiri M, Golsorkhtabaramiri M, Esmaeilzadeh S, et al. Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese/overweight pcos women under hypocaloric diet. J Reproduc Infertility. 2014;15(4):205–213.
   PubMedGoogle Scholar
• Esfahanian F, Zamani MM, Heshmat R, et al. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2013;39(4):806–813.
   PubMed Web of Science ®Google Scholar
• Ladson G, Dodson WC, Sweet SD, et al. The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril. 2011;95(3):1059–1066 e1-7.
   PubMed Web of Science ®Google Scholar
• Panidis D, Tziomalos K, Papadakis E, et al. The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration. Hormones. 2013;12(2):192–200.
   PubMedGoogle Scholar
• Helena T, Marie M, Michael C, et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome. 2018.
   Google Scholar
• Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metabol. 2000;85(1):139–146.
   PubMed Web of Science ®Google Scholar
• Morley LC, Tang T, Yasmin E, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11(11):CD003053.
   PubMedGoogle Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Miller JJ. The Inverse of the freeman – tukey double arcsine transformation. Am Statistician. 1978;32(4):138–138.
   Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Wetterslev J, Jakobsen JC, Gluud C. Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39.
   PubMed Web of Science ®Google Scholar
• Curi DD, Fonseca AM, Marcondes JA, et al. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28(3):182–185.
   PubMed Web of Science ®Google Scholar
• Fux Otta C, Wior M, Iraci GS, et al. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Gynecol Endocrinol. 2010;26(3):173–178.
   PubMed Web of Science ®Google Scholar
• Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clinical Endocrinol Metabol. 2006;91(10):3970–3980.
   PubMed Web of Science ®Google Scholar
• Ladson G, Dodson WC, Sweet SD, et al. Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Fertil Steril. 2011;95(8):2595–2598 e1-6.
   PubMed Web of Science ®Google Scholar
• Pagotto U, Gambineri A, Vicennati V, et al. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metabol. 2002;87(12):5625–5629.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab. 2000;85(8):2767–2774.
   PubMed Web of Science ®Google Scholar
• Qublan HS, Yannakoula EK, Al-Qudah MA, et al. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. Saudi Med J. 2007;28(11):1694–1699.
   PubMed Web of Science ®Google Scholar
• Tang T, Glanville J, Hayden CJ, et al. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Human Reproduc. 2006;21(1):80–89.
   PubMed Web of Science ®Google Scholar
• Carmina E, Campagna AM, Lobo RA. A 20-year follow-up of young women with polycystic ovary syndrome. Obstetr Gynecol. 2012;119(2 Pt 1):263–269.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Spritzer PM, Sir-Petermann T, et al. Insulin resistance and polycystic ovary syndrome through life. Curr Pharm Des. 2012;18(34):5569–5576.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Graf M, Mandeli J, et al. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 1987;65(3):499–507.
   PubMed Web of Science ®Google Scholar
• Robinson S, Kiddy D, Gelding SV, et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol. 1993;39(3):351–355.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest. 1989;83(1):23–29.
   PubMed Web of Science ®Google Scholar
• Franks S, Gilling-Smith C, Watson H, et al. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am. 1999;28(2):361–378.
   PubMed Web of Science ®Google Scholar
• Kravariti M, Naka KK, Kalantaridou SN, et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2005;90(9):5088–5095.
   PubMed Web of Science ®Google Scholar
• Paradisi G, Steinberg HO, Hempfling A, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001;103(10):1410–1415.
   PubMed Web of Science ®Google Scholar
• Ciaraldi TP, el-Roeiy A, Madar Z, et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1992;75(2):577–583.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Xia J, Book CB, et al. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 1995;96(2):801–810.
   PubMed Web of Science ®Google Scholar
• Venkatesan AM, Dunaif A, Corbould A. Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res. 2001;56:295–308.
   PubMedGoogle Scholar
• Li W, Ma L, Li Q. Insulin resistance but not impaired β-cell function: a key feature in Chinese normal-weight PCOS women with normal glucose regulation. Gynecol Endocrinol. 2012;28(8):598–601.
   PubMed Web of Science ®Google Scholar
• Hurliman A, Keller Brown J, Maille N, et al. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS). Endocrinology. 2015;156(11):4071–4080.
   PubMed Web of Science ®Google Scholar
• Bridges HR, Jones AJ, Pollak MN, et al. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J. 2014;462(3):475–487.
   PubMed Web of Science ®Google Scholar
• Lord JM, White SI, Bailey CJ, et al. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes. Br Med J. 1983;286(6368):830–831.
   PubMedGoogle Scholar
• Fullerton MD, Galic S, Marcinko K, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med. 2013;19(12):1649–1654.
   PubMed Web of Science ®Google Scholar
• Kim CH, Chon SJ, Lee SH. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis. Sci Rep. 2020;10(1):7802.
   PubMed Web of Science ®Google Scholar
• Otto-Buczkowska E, Grzyb K, Jainta N. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty. Pediatr Endocrinol Diabetes Metab. 2018;24(1):40–44.
   PubMedGoogle Scholar
• Johnston CS, Sears B, Perry M, et al. Use of novel high-protein functional food products as part of a calorie-restricted diet to reduce insulin resistance and increase lean body mass in adults: a randomized controlled trial. Nutrients. 2017;9(11):1182.
   Web of Science ®Google Scholar
• Yarar-Fisher C, Li J, McLain A, et al. Utilizing a low-carbohydrate/high-protein diet to improve metabolic health in individuals with spinal cord injury (DISH): study protocol for a randomized controlled trial. Trials. 2019;20(1):466.
   PubMedGoogle Scholar
• Wang B, Smyl C, Chen CY, et al. Suppression of postprandial blood glucose fluctuations by a low-carbohydrate, high-protein, and high-omega-3 diet via inhibition of gluconeogenesis. IJMS. 2018;19(7):1823.
   Google Scholar
• Jakubowicz D, Wainstein J, Landau Z, et al. High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA(1C) in Type 2 diabetes. J Nutr Biochem. 2017;49:1–7.
   PubMed Web of Science ®Google Scholar
• Samkani A, Skytte MJ, Kandel D, et al. A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients. Br J Nutr. 2018;119(8):910–917.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Ko H, Misso M, et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 2013;113(4):520–545.
   PubMed Web of Science ®Google Scholar
• Marsh KA, Steinbeck KS, Atkinson FS, et al. Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. Am J Clin Nutr. 2010;92(1):83–92.
   PubMed Web of Science ®Google Scholar
• González F, Considine RV, Abdelhadi OA, et al. Oxidative stress in response to saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(11):5360–5371.
   PubMed Web of Science ®Google Scholar
• Yogalakshmi B, Bhuvaneswari S, Sreeja S, et al. Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet. J Cell Commun Signal. 2014;8(1):13–22.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wu Y, Huang Q. Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis. Arch Gynecol Obstet. 2017;296(4):661–677.
   PubMed Web of Science ®Google Scholar
• Brettenthaler N, De Geyter C, Huber PR, et al. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2004;89(8):3835–3840.
   PubMed Web of Science ®Google Scholar
• Aigner E, Bachofner N, Klein K, et al. Retinol-binding protein 4 in polycystic ovary syndrome-association with steroid hormones and response to pioglitazone treatment. J Clin Endocrinol Metab. 2009;94(4):1229–1235.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Unfer V. Reflections on inositol(s) for PCOS therapy: steps toward success. Gynecol Endocrinol. 2015;31(7):501–505.
   PubMed Web of Science ®Google Scholar
• Unfer V, Nestler JE, Kamenov ZA, et al. Effects of inositol(s) in women with PCOS: a systematic review of randomized controlled trials. Int J Endocrinol. 2016;2016:1849162.
   PubMed Web of Science ®Google Scholar
• Romualdi D, Versace V, Lanzone A. What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment. Ther Adv Reprod Health. 2020;14:2633494120908709.
   Google Scholar
• Genazzani AD, Shefer K, Della Casa D, et al. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Invest. 2018;41(5):583–590.
   PubMed Web of Science ®Google Scholar
• De Cicco S, Immediata V, Romualdi D, et al. Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action. Gynecol Endocrinol. 2017;33(9):698–701.
   PubMed Web of Science ®Google Scholar
• Cappelli V, Di SA, Musacchio MC, et al. Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS. Minerva Ginecol. 2013;65(4):425–433.
   PubMedGoogle Scholar
• Kite C, Lahart IM, Afzal I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Syst Rev. 2019;8(1):51.
   PubMedGoogle Scholar
• Dos Santos IK, Ashe MC, Cobucci RN, et al. The effect of exercise as an intervention for women with polycystic ovary syndrome: A systematic review and meta-analysis. Medicine. 2020;99(16):e19644.
   PubMed Web of Science ®Google Scholar
• Tiwari N, Pasrija S, Jain S. Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2019;234:149–154.
   PubMed Web of Science ®Google Scholar
• Wang A, Mo T, Li Q, et al. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis. Endocrine. 2019;64(2):220–232.
   PubMed Web of Science ®Google Scholar